The practical management of cognitive impairment and psychosis in the older Parkinson’s disease patient

Nonpharmacological enhancement of cognitive function in Parkinson's disease: A systematic review

(2013) John V. Hindle et al.   MOVEMENT DISORDERS

Comparative Safety of Antipsychotic Medications in Nursing Home Residents

(2012) Krista F. Huybrechts et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia

(2011) Daniel Weintraub et al.   American Journal of Alzheimers Disease and Other Dementias

Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis

(2011) Daniel Weintraub   ARCHIVES OF NEUROLOGY

Dementia Medications and Risk of Falls, Syncope, and Related Adverse Events: Meta-Analysis of Randomized Controlled Trials

(2011) Dae Hyun Kim et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The interplay of cholinergic function, attention, and falls in Parkinson's disease

(2011) Alison Yarnall et al.   MOVEMENT DISORDERS

Ageing, neurodegeneration and Parkinson's disease

(2010) J. V. Hindle   AGE AND AGEING

Management of hallucinations and psychosis in Parkinson's disease

(2010) Marty L. Eng et al.   American Journal Geriatric Pharmacotherapy

A 12-Year Population-Based Study of Psychosis in Parkinson Disease

(2010) Elin B. Forsaa et al.   ARCHIVES OF NEUROLOGY

Potential Cardiotoxic Reaction Involving Rivastigmine and Beta-Blockers: A Case Report and Review of the Literature

(2010) Barbara Paulison et al.   Cardiovascular Toxicology

Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data

(2010) Teus van Laar et al.   CNS Neuroscience & Therapeutics

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial

(2010) Maarten MJ van Eijk et al.   LANCET

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

(2010) Murat Emre et al.   LANCET NEUROLOGY

The safety and tolerability of clozapine in aged patients: A retrospective clinical file review

(2010) Daniel W. O'Connor et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors

(2009) Sudeep S. Gill et al.   ARCHIVES OF INTERNAL MEDICINE

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

(2009) Dag Aarsland et al.   LANCET NEUROLOGY

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

(2009) Iracema Leroi et al.   MOVEMENT DISORDERS

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype

(2008) J-P Taylor et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Predisposing and precipitating factors for delirium in a frail geriatric population

(2008) Jouko V. Laurila et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS